DEFINITIVE ADDITIONAL MATERIALS

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No.     )

 

Filed by the Registrant     x

Filed by a Party other than the Registrant    ¨

Check the appropriate box:

 

¨   Preliminary Proxy Statement   ¨   

Confidential, for Use of the Commission Only

(as permitted by Rule 14a-6(e)(2))

¨   Definitive Proxy Statement     
x   Definitive Additional Materials     
¨   Soliciting Material Pursuant to §240.14a-12     

Bristol-Myers Squibb Company

 

(Name of Registrant as Specified In Its Charter)

 

  

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

 

x    No fee required
¨    Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11
   (1)    Title of each class of securities to which transaction applies:
     

 

   (2)    Aggregate number of securities to which transaction applies:
     

 

   (3)    Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
     

 

   (4)    Proposed maximum aggregate value of transaction:
     

 

   (5)    Total fee paid:
     

 

¨    Fee paid previously with preliminary materials.
¨    Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
   (1)    Amount Previously Paid:
     

 

   (2)    Form, Schedule or Registration Statement No.:
     

 

   (3)    Filing Party:
     

 

   (4)    Date Filed:
     

 


*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Annual Meeting of Stockholders to Be Held on May 7, 2013.

 

          

 

Meeting Information            

   
BRISTOL-MYERS SQUIBB COMPANY         Meeting Type:     Annual Meeting of Stockholders    
       

 

For holders as of:

 

 

  03/14/13

   
          

 

Date:   05/07/13

 

 

  Time:     10:00 A.M.

   
          

 

Location:    Bristol-Myers Squibb Company

   
          

 777 Scudders Mill Road

   
LOGO        

 Plainsboro, NJ 08536

 

For directions to the meeting, please see the inside back cover of the Proxy Statement or call the company at (609) 897-2000.

 

   

P.O. BOX 4000

PRINCETON, NJ 08540

   

You are receiving this communication because you hold shares in the company named above.

   

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

   

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

     

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 

M54229-P34769


      Before You Vote        
        

How to Access the Proxy Materials

 

Proxy Materials Available to VIEW or RECEIVE:    

 

1. NOTICE AND PROXY STATEMENT        2. ANNUAL REPORT

 

How to View Online:

Have the information that is printed in the box marked by the arrow LOGO (located on the following page) and visit: www.proxyvote.com.

 

How to Request and Receive a PAPER or E-MAIL Copy:

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

 

                                 1) BY INTERNET:         www.proxyvote.com

                                 2) BY TELEPHONE:     1-800-579-1639

                                 3) BY E-MAIL*:             sendmaterial@proxyvote.com

 

*   If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow LOGO (located on the following page) in the subject line.

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. To facilitate timely delivery, please make the request as instructed above on or before 4/23/13.

 

   
      How To Vote        
        

Please Choose One of the Following Voting Methods

 

      

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to WWW.PROXYVOTE.COM. Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m., Eastern Time either on (i) May 2, 2013 for shares in employee benefit plans, or (ii) May 6, 2013 for all other shares. Have this Notice in hand when you access the website and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a voting instruction form.

 

    

M54230-P34769


Voting Items      

 

THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” EACH DIRECTOR UNDER ITEM 1.    THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” ITEMS 2 AND 3.
1.    Election of Directors    2.    Ratification of the Appointment of Independent
  

 

Nominees:

      Registered Public Accounting Firm.
   1A)    L. Andreotti    3.    Advisory Vote to Approve the Compensation of our Named Executive Officers.
  

 

1B)

  

 

L. B. Campbell

     
  

 

1C)

  

 

J. M. Cornelius

     
   1D)    L. H. Glimcher, M.D.      
   1E)    M. Grobstein      
   1F)    A. J. Lacy      
   1G)    V. L. Sato, Ph.D.      
   1H)    E. Sigal, M.D., Ph.D.      
   1I)    G. L. Storch      
   1J)    T. D. West, Jr.      

M54231-P34769


 

 

 

M54232-P34769